fill-finish facility

Actionable Insights Powered by AI

Novo Nordisk Invests $4.1 Billion in New US Manufacturing Site, Abandoning Irish Plans

Novo Nordisk, US manufacturing site, obesity drugs, fill-finish facility, Clayton, NC, Irish build